Clinical mass spectrometry: from basic research to drug monitoring and toxicology

14 Giugno Giu 2024 0930 9 days ago 14 Giugno Giu 2024 1600 9 days ago

This workshop aims to discuss the importance of mass spectrometry in clinical research.

It will provide insights into the latest trends and tools that impact biomarker research. Clinical mass spectrometry proteomics assays are increasingly used in clinical laboratories to analyze peptides and proteins for diagnosis, toxicology, and pharmacological purposes. It is, therefore, urgent to characterize and validate the methods available for liquid chromatography-tandem mass spectrometry targeted quantification of peptide and protein biomarkers in biological fluids in the context of in-vitro diagnostics.

The workshop aims to encourage participants from academia, industry, national research societies, and instrument vendors to interact and create new collaborations between multiple disciplines and participating countries.

Scientific & Organizing Committee

Cristina Banfi - Responsabile dell’Unità di Proteomica e Metabolomica, Centro Cardiologico Monzino

Andrea Armirotti - Presidente della Società IMaSS, Istituto Italiano di Tecnologia, Genova

Giuseppe Pieraccini - Responsabile Centro di servizi di Spettrometria di Massa, Università di Firenze